Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline to improve filarial lymphedema
PACTR201708002420261Not yet recruiting
- Sponsor
- Kumasi Centre for Collaborative Research in Tropical Medicine
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of doxycycline in filariasis (3 arms), sponsored by Kumasi Centre for Collaborative Research in Tropical Medicine. Primary endpoint: Lack of progression of lymphedema at 24 months. Planned start Oct 2017; status: not yet recruiting.
02
Drugs
doxycycline
03
Conditions
filariasis
Beyond the preview
Go deeper on PACTR201708002420261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201708002420261.